Cyrille Sur

8.7k total citations · 3 hit papers
90 papers, 5.5k citations indexed

About

Cyrille Sur is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Cyrille Sur has authored 90 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Cellular and Molecular Neuroscience, 49 papers in Molecular Biology and 18 papers in Physiology. Recurrent topics in Cyrille Sur's work include Neuroscience and Neuropharmacology Research (48 papers), Receptor Mechanisms and Signaling (25 papers) and Amino Acid Enzymes and Metabolism (15 papers). Cyrille Sur is often cited by papers focused on Neuroscience and Neuropharmacology Research (48 papers), Receptor Mechanisms and Signaling (25 papers) and Amino Acid Enzymes and Metabolism (15 papers). Cyrille Sur collaborates with scholars based in United States, United Kingdom and France. Cyrille Sur's co-authors include John Atack, Ruth M. McKernan, Gene G. Kinney, Paul J. Whiting, Owain W. Howell, Patrick D. Schloss, Heinrich Betz, P. Jeffrey Conn, David L. Williams and Marlene A. Jacobson and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Neuroscience.

In The Last Decade

Cyrille Sur

89 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enhanced Learning and Memory and Altered GABAergic Synaptic Transmission in Mice Lacking the α5 Subunit of the GABA_AReceptor

2002 509 citations Cyrille Sur, Owain W. Howell et al. profile →
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease

2018 471 citations Cyrille Sur et al. profile →
Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease

2019 380 citations Cyrille Sur et al. profile →

Peers

Countries citing papers authored by Cyrille Sur

Since Specialization

Citations

This map shows the geographic impact of Cyrille Sur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cyrille Sur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cyrille Sur more than expected).

Fields of papers citing papers by Cyrille Sur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cyrille Sur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cyrille Sur. The network helps show where Cyrille Sur may publish in the future.

Co-authorship network of co-authors of Cyrille Sur

This figure shows the co-authorship network connecting the top 25 collaborators of Cyrille Sur. A scholar is included among the top collaborators of Cyrille Sur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cyrille Sur. Cyrille Sur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A dual-time-window protocol to reduce acquisition time of dynamic tau PET imaging using [18F]MK-6240 2021 ·EJNMMI Research ·(unknown), David Vállez García, Talakad G. Lohith, Eric D. Hostetler, Cyrille Sur, Arie Struyk, Ronald Boellaard, Michel Koole	11
2	The M1 Muscarinic Receptor Allosteric Agonists AC-42 and 1-[1′-(2-Methylbenzyl)-1,4′-bipiperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one Bind to a Unique Site Distinct from the Acetylcholine Orthosteric Site 2010 ·Molecular Pharmacology ·Marlene A. Jacobson, Constantine Kreatsoulas, Danette Pascarella, Julie A. O’Brien, Cyrille Sur	24
3	Recent Progress in the Discovery of Non-Sarcosine Based GlyT1 Inhibitors 2010 ·Current Topics in Medicinal Chemistry ·S. E. Wolkenberg, Cyrille Sur	23
4	Inhibition of Tumor Growth Progression by Antiandrogens and mTOR Inhibitor in a Pten -Deficient Mouse Model of Prostate Cancer 2009 ·Cancer Research ·Weisheng Zhang, Joe Jiang Zhu, Clay L. Efferson, Chris Ware, Jennifer Tammam, Minilik Angagaw, Jason Laskey, (unknown), Shailaja Kasibhatla, John F. Reilly, Cyrille Sur, Pradip K. Majumder	66
5	In Vivo Optical Imaging of LacZ Expression Using lacZ Transgenic Mice 2009 ·Assay and Drug Development Technologies ·Guo‐Jun Zhang, Tsing‐Bau Chen, Brett Connolly, Shu-An Lin, Richard Hargreaves, Amy Vanko, Bohumil Bednář, Douglas J. MacNeil, Cyrille Sur, David L. Williams	7
6	Inverse agonist histamine H3 receptor PET tracers labelled with carbon‐11 or fluorine‐18 2009 ·Synapse ·Terence G. Hamill, Nagaaki Sato, Makoto Jitsuoka, Shigeru Tokita, Sandra Sanabria, Waisi Eng, Christine Ryan, Stephen M. Krause, Norihiro Takenaga, Shil Patel, Zhizhen Zeng, David L. Williams, Cyrille Sur, Richard Hargreaves, H. Donald Burns	30
7	Discovery of N-{[1-(propylsulfonyl)-4-pyridin-2-ylpiperidin-4-yl]methyl}benzamides as novel, selective and potent GlyT1 inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Zhijian Zhao, William Leister, Julie A. O’Brien, Wei Lemaire, David L. Williams, Marlene A. Jacobson, Cyrille Sur, Gene G. Kinney, D. J. PETTIBONE, Philip R. Tiller, Sheri Smith, George D. Hartman, Craig W. Lindsley, S. E. Wolkenberg	16
8	Synthesis and SAR of GlyT1 inhibitors derived from a series of N-((4-(morpholine-4-carbonyl)-1-(propylsulfonyl)piperidin-4-yl)methyl)benzamides 2006 ·Bioorganic & Medicinal Chemistry Letters ·Zhijian Zhao, Julie A. O’Brien, Wei Lemaire, David L. Williams, Marlene A. Jacobson, Cyrille Sur, D. J. PETTIBONE, Philip R. Tiller, Sheri Smith, George D. Hartman, S. E. Wolkenberg, Craig W. Lindsley	12
9	Design, Synthesis, and In Vivo Efficacy of Glycine Transporter‐1 (GlyT1) Inhibitors Derived from a Series of [4‐Phenyl‐1‐(propylsulfonyl)piperidin‐4‐yl]methyl Benzamides 2006 ·ChemMedChem ·Craig W. Lindsley, Zhijian Zhao, William Leister, (unknown), Wei Lemaire, David L. Williams, Tsing‐Bau Chen, Raymond S.L. Chang, Maryann Burno, Marlene A. Jacobson, Cyrille Sur, Gene G. Kinney, Douglas J. Pettibone, Philip R. Tiller, Sheri Smith, Nancy N. Tsou, Mark E. Duggan, P. Jeffrey Conn, George D. Hartman	32
10	Challenges in the development of mGluR5 positive allosteric modulators: The discovery of CPPHA 2006 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), David D. Wisnoski, Julie A. O’Brien, Wei Lemaire, David L. Williams, Marlene A. Jacobson, (unknown), Sookhee Ha, Hervé Schaffhauser, Cyrille Sur, D. J. PETTIBONE, Mark E. Duggan, P. Jeffrey Conn, George D. Hartman, Craig W. Lindsley	58
11	A Novel Selective Allosteric Modulator Potentiates the Activity of Native Metabotropic Glutamate Receptor Subtype 5 in Rat Forebrain 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Julie A. O’Brien, Wei Lemaire, Marion Wittmann, Marlene A. Jacobson, Sookhee Ha, David D. Wisnoski, Craig W. Lindsley, Hervé Schaffhauser, Blake A. Rowe, Cyrille Sur, Mark E. Duggan, Douglas J. Pettibone, P. Jeffrey Conn, David L. Williams	132
12	Sedation and anesthesia mediated by distinct GABA(A) receptor isoforms. 2003 ·PubMed Central ·David S. Reynolds, Thomas W. Rosahl, Jennifer Cirone, Gillian F. O’Meara, (unknown), Richard J. Newman, (unknown), Cyrille Sur, Owain W. Howell, A. Richard Rutter, John Atack, Alison Macaulay, Karen L. Hadingham, Peter H. Hutson, Delia Belelli, Jeremy J. Lambert, Gerard R. Dawson, Ruth M. McKernan, Paul J. Whiting, Keith A. Wafford	240
13	A Family of Highly Selective Allosteric Modulators of the Metabotropic Glutamate Receptor Subtype 5 2003 ·Molecular Pharmacology ·Julie A. O’Brien, Wei Lemaire, Tsing‐Bau Chen, Raymond S.L. Chang, Marlene A. Jacobson, Sookhee Ha, Craig W. Lindsley, Hervé Schaffhauser, Cyrille Sur, Douglas J. Pettibone, P. Jeffrey Conn, David L. Williams	170
14	Pharmacology and expression analysis of glycine transporter GlyT1 with [3H]-(N-[3-(4′-fluorophenyl)-3-(4′phenylphenoxy)propyl])sarcosine 2003 ·Neuropharmacology ·Pierre Mallorga, Jacinta B. Williams, Marlene A. Jacobson, (unknown), Ashok Chaudhary, P. Jeffrey Conn, Douglas J. Pettibone, Cyrille Sur	56
15	The 5-HT2B agonist, CP93129, inhibits GABA release from slices of rat globus pallidus and reverses akinesia following intrapallidal administration in the reserpine-treated rat 2000 ·British Journal of Pharmacology ·(unknown), John Atack, Cyrille Sur, Susan Duty	2
16	The 5HT_1B receptor agonist, CP‐93129, inhibits [³H]‐GABA release from rat globus pallidus slices and reverses akinesia following intrapallidal injection in the reserpine‐treated rat 2000 ·British Journal of Pharmacology ·(unknown), Cyrille Sur, John Atack, Susan Duty	48
17	Changes in [3H]zolpidem and [3H]Ro 15-1788 binding in rat globus pallidus and substantia nigra pars reticulata following a nigrostriatal tract lesion 2000 ·Brain Research ·(unknown), Owain W. Howell, John Atack, Cyrille Sur, Susan Duty	12
18	Subcellular Localization of the GABA_A Receptor γ2 Subunit in the Rat Spinal Cord 1995 ·European Journal of Neuroscience ·Cyrille Sur, Ruth M. McKernan, Antoine Triller	18
19	Morphology of the release site of inhibitory synapses on the soma and dendrite of an identified neuron 1995 ·The Journal of Comparative Neurology ·Cyrille Sur, Antoine Triller, Henri Korn	19
20	The inhibitory neuronal glycine receptor 1994 ·BioEssays ·Catherine Béchade, Cyrille Sur, Antoine Triller	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact